Why Metsera stock's 20% surge signals a fierce Pfizer-Novo Nordisk bidding war
Metsera Inc(US:MTSR) Invezz·2025-11-05 02:02Metsera stock (NASDAQ: MTSR) surged roughly 20% on Tuesday after the obesity-focused biotech announced that Novo Nordisk's revised $10 billion acquisition proposal has been deemed "superior†to Pfizer... ...